Dr. Mayka Sánchez attended the LXV National Congress of SEHH and XXXIX National Congress of SETH to discuss her new paper, which was carried out jointly with her research team from the International University of Catalonia (UIC). All reported cases of CDA III present with a core phenotype consisting of a…
BLOODGENETICS signed a collaboration agreement with CIEMAT and Dr José Carlos Segovia Sanz group for the future development of Gene Therapy in Congenital Dyserythropoietic Anemia in the Neotec2019 application context. Thanks to the patient association ADISCON support!
BLOODGENETICS gets an ENISA loan for young entrepreneurs!! ENISA depends on the Spanish Ministry of industry, trade and tourism and gives financial support to small and middle-sized companies with transformation potential, which are committed to entrepreneurship and innovation. We are very excited for having this support of the Spanish Government and committed to a social…
New contribution of BLOODGENETICS and UIC to ferritin diseases. One gene five diseases: hereditary hyperferritinemia with cataracts, benign hyperferritinemia, neuroferritinopathy, L-ferritin deficiency dominant, L-ferritin deficiency recessive. Follow the link to read the article: https://www.mdpi.com/1424-8247/12/1/17
BLOODGENETICS has been awarded with two contracts from the Spanish Ministry of Economy and Competitiveness: Postdoctoral position Torres Quevedo for three years Industrial Doctorate for four years
Accepted Publication in Haematologica Journal (impact factor: 9.090) with contribution from BLOODGENETICS The manuscript: «The phenotypic spectrum of germline YARS2 variants: from sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2» by Lisa G. Riley and colleagues has recently been accepted in the prestigious journal Haematologica. This work is a collaboration of researchers…
Dr. Mayka Sanchez (Josep Carreras Leukemia Research Institute and cofounder of BloodGenetics) held a seminar on April 4th at Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, in collaboration with the Unit of Hematology, Oncology and Hematopoietic Transplantation with the title “Hematological and neurological diseases due to homeostatic dysfunction of iron metabolism” Synopsis…
BLOODGENETICS has been granted with the Santander CRUE CEPYME Fellowship, a program aimed at completing the training of students from Spanish universities, bringing reality closer to the professional field, expanding their knowledge and favoring their contact with companies to facilitate their labor insertion. Thanks to this fellowship we will continue to complete our database,…
BLOODGENETICS has participated in the European Iron Club held in Zürich from 8th to 11th February, 2018. We presented the following poster: CLINICAL DIAGNOSIS BY NEXT GENERATION SEQUENCING OF HEREDITARY HAEMATOLOGICAL DISEASES. Sònia Sabaté-Soler, Josep Fita-Torró, Beatriz Cadenas-Sevilla, Clara Esteban-Jurado, David Beneitez-Pastor, Jose Luis Dapena, Adoración Blanco-Alvarez, Eugènia Rivero-Arango, José Luis Fuster, Mar Bermúdez-Cortés,…
BLOODGENETICS at the I Genetic Interhospital Conference of Catalonia The BloodGenetics team will attend the I Interhospital Conference of Catalonia to be held at the Hospital de Sant Pau (Barcelona) on November 27th. During the conference we will participate in the roundtable in which the company-hospital relationship will be discussed. Also we will announce our…